These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
659 related articles for article (PubMed ID: 27421788)
1. STK25 is a critical determinant in nonalcoholic steatohepatitis. Amrutkar M; Chursa U; Kern M; Nuñez-Durán E; Ståhlman M; Sütt S; Borén J; Johansson BR; Marschall HU; Blüher M; Mahlapuu M FASEB J; 2016 Oct; 30(10):3628-3643. PubMed ID: 27421788 [TBL] [Abstract][Full Text] [Related]
2. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH. Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431 [TBL] [Abstract][Full Text] [Related]
3. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease. Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769 [TBL] [Abstract][Full Text] [Related]
4. Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans. Cansby E; Kulkarni NM; Magnusson E; Kurhe Y; Amrutkar M; Nerstedt A; Ståhlman M; Sihlbom C; Marschall HU; Borén J; Blüher M; Mahlapuu M FASEB J; 2019 Sep; 33(9):9974-9989. PubMed ID: 31173506 [TBL] [Abstract][Full Text] [Related]
5. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia. Cansby E; Magnusson E; Nuñez-Durán E; Amrutkar M; Pedrelli M; Parini P; Hoffmann J; Ståhlman M; Howell BW; Marschall HU; Borén J; Mahlapuu M Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1723-1737. PubMed ID: 29930001 [TBL] [Abstract][Full Text] [Related]
6. Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans. Amrutkar M; Kern M; Nuñez-Durán E; Ståhlman M; Cansby E; Chursa U; Stenfeldt E; Borén J; Blüher M; Mahlapuu M Diabetologia; 2016 Feb; 59(2):341-53. PubMed ID: 26553096 [TBL] [Abstract][Full Text] [Related]
8. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model. Amrutkar M; Cansby E; Chursa U; Nuñez-Durán E; Chanclón B; Ståhlman M; Fridén V; Mannerås-Holm L; Wickman A; Smith U; Bäckhed F; Borén J; Howell BW; Mahlapuu M Diabetes; 2015 Aug; 64(8):2791-804. PubMed ID: 25845663 [TBL] [Abstract][Full Text] [Related]
9. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet. Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140 [TBL] [Abstract][Full Text] [Related]
10. Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis. Zhang M; Zhao Y; Li Z; Wang C Biochem Biophys Res Commun; 2018 Jan; 495(1):582-586. PubMed ID: 29128353 [TBL] [Abstract][Full Text] [Related]
11. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023 [TBL] [Abstract][Full Text] [Related]
12. Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice. Nuñez-Durán E; Aghajan M; Amrutkar M; Sütt S; Cansby E; Booten SL; Watt A; Ståhlman M; Stefan N; Häring HU; Staiger H; Borén J; Marschall HU; Mahlapuu M Hepatol Commun; 2018 Jan; 2(1):69-83. PubMed ID: 29404514 [TBL] [Abstract][Full Text] [Related]
13. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency. Kim M; Yoo G; Randy A; Kim HS; Nho CW Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27981809 [TBL] [Abstract][Full Text] [Related]
14. Hepatocyte-specific clusterin overexpression attenuates diet-induced nonalcoholic steatohepatitis. Park JS; Shim YJ; Kang BH; Lee WK; Min BH Biochem Biophys Res Commun; 2018 Jan; 495(2):1775-1781. PubMed ID: 29229391 [TBL] [Abstract][Full Text] [Related]
15. p16 deficiency promotes nonalcoholic steatohepatitis via regulation of hepatic oxidative stress. Lv F; Wu J; Miao D; An W; Wang Y Biochem Biophys Res Commun; 2017 Apr; 486(2):264-269. PubMed ID: 28286271 [TBL] [Abstract][Full Text] [Related]
16. Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet. Tanaka N; Takahashi S; Hu X; Lu Y; Fujimori N; Golla S; Fang ZZ; Aoyama T; Krausz KW; Gonzalez FJ Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3170-3182. PubMed ID: 28844958 [TBL] [Abstract][Full Text] [Related]
17. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis. Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482 [TBL] [Abstract][Full Text] [Related]
18. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695 [TBL] [Abstract][Full Text] [Related]
19. Antagonizing STK25 Signaling Suppresses the Development of Hepatocellular Carcinoma Through Targeting Metabolic, Inflammatory, and Pro-Oncogenic Pathways. Kurhe Y; Caputo M; Cansby E; Xia Y; Kumari S; Anand SK; Howell BW; Marschall HU; Mahlapuu M Cell Mol Gastroenterol Hepatol; 2022; 13(2):405-423. PubMed ID: 34624527 [TBL] [Abstract][Full Text] [Related]
20. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis. Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]